Positive patent news for Iconovo’s multidose inhaler
The European Patent Organization, EPO, has announced the intention to grant a patent regarding Iconovo’s inhalation device, ICOres. Iconovo has previously three granted Swedish patents and two granted European patents (EPO) on ICOres. The new patent covers the technology used in many of Iconovo’s projects like generic Symbicort©.
“This patent provides protection of a very important and fundamental function in ICOres. This additional patent strengthens our intellectual property and increases the value of our product portfolio”, says Johan Wäborg, CEO.